Modern Healthspan: Longevity Drug Protects Immune Cells from DNA Damage #shorts

ByLongevity Notes Editorial
🟢
Peer-Reviewed Research
M
Modern Healthspan

Video Summary · February 14, 2026

View Full Protocol →

Key Takeaways

  • Rapamycin (an mTOR inhibitor) reduced DNA damage in human T-cells during lab tests, improving survival under DNA stress.
  • In a small human pilot, older adults taking 1 mg Rapamycin daily for 4 months showed reduced immune cell DNA damage vs. placebo.
  • This daily microdose differs from the common intermittent weekly dosing (cycling mTOR inhibition).
  • DNA damage reduction in immune cells may slow aging—prioritize interventions that target this mechanism.

Supplements & Protocols Mentioned

  • Rapamycin – 1 mg daily dose (continuous), alternative to the intermittent weekly dosing approach.

Bottom Line

Consider discussing Rapamycin dosing strategies with a longevity-savvy physician, as daily microdosing (vs. weekly) may better protect immune cells from DNA damage.

Explore supplements mentioned in this video

Shop on iHerb →

Explore More

Watch the Full Video

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

From Our Research Network

Part of the Evidence-Based Research Network

Similar Posts